Skip to Content
MilliporeSigma

H6660

HIV Protease Substrate 1

≥95% (HPLC), powder

Synonym(s):

Arg-Glu(EDANS)-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Lys(DABCYL)-Arg

Slide 1 of 1
Sign In to View Organizational & Contract Pricing.

Select a Size

1 MG

$658.00

$658.00

Available to ship TODAYDetails

About This Item

UNSPSC Code:
12352204
NACRES:
NA.32
MDL number:
MFCD00283442

Key Documents

View All Documentation

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

HIV Protease Substrate 1,

assay

≥95% (HPLC)

form

powder

mol wt

2016

solubility

DMSO: soluble

storage temp.

−20°C

Quality Level

200

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
R8276G7923T3410
HIV Protease Substrate 1

Sigma-Aldrich

H6660

HIV Protease Substrate 1

Renin Substrate 1

Sigma-Aldrich

R8276

Renin Substrate 1

GO-201 trifluoroacetate salt ≥95% (HPLC)

Sigma-Aldrich

G7923

GO-201 trifluoroacetate salt

Thymosin α1 bovine ≥90% (HPLC)

Sigma-Aldrich

T3410

Thymosin α1 bovine

assay

≥95% (HPLC)

assay

>85.0% (HPLC)

assay

≥95% (HPLC)

assay

≥90% (HPLC)

solubility

DMSO: soluble

solubility

water: 1 mg/mL, clear, orange to red

solubility

H2O: >1 mg/mL

solubility

-

Quality Level

200

Quality Level

200

Quality Level

100

Quality Level

-

form

powder

form

powder

form

lyophilized

form

powder

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

mol wt

2016

mol wt

~2281

mol wt

-

mol wt

-

Application

HIV Protease Substrate 1 has been used:
  • to study protein structure-function relationships and in the fluorescent assay[1]
  • to evaluate protease inhibitors and for in vitro detection of the HIV-1 protease activity[2]
  • and in protease kinetics to study its enzymatic degradation rates[3]

Biochem/physiol Actions

HIV Protease Substrate 1 is a synthetic peptide sequence that contains the cleavage site (Tyr-Pro) for the human immunodeficiency virus (HIV) Protease. It has two covalently modified amino acids for the detection of cleavage. One modification is the addition of the fluorophore 5-(2-aminoethylamino)-1-naphthalene sulfonate (EDANS) to the glutamic acid residue, while the other one includes the addition of the acceptor chromophore 4c-dimethylaminoazobenzene-4-carboxylate (DABCYL) to the lysine residue. The modified amino acids are on opposite sides of the cleavage site. Spatial orientation and overlap of the DABCYL absorbance with the EDANS emission permit resonance energy transfer between the two moieties. However, when the peptide is cleaved by the HIV protease, the DABCYL group is no longer proximal to the fluorophore.[1]
Substrate for endopeptidases

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000257407
SLCR5662
SLCR5662
0000257407
SLCQ4672

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Rok Gaber et al.
Sensors (Basel, Switzerland), 13(12), 16330-16346 (2013-11-30)
To effectively fight against the human immunodeficiency virus infection/ acquired immunodeficiency syndrome (HIV/AIDS) epidemic, ongoing development of novel HIV protease inhibitors is required. Inexpensive high-throughput screening assays are needed to quickly scan large sets of chemicals for potential inhibitors. We
Jason Segura et al.
PloS one, 18(2), e0281087-e0281087 (2023-02-14)
HIV infection remains incurable to date and there are no compounds targeted at the viral release. We show here HIV viral release is not spontaneous, rather requires caspases activation and shedding of its adhesion receptor, CD62L. Blocking the caspases activation
Nancy Cheng et al.
Journal of laboratory automation, 19(3), 297-303 (2013-12-07)
Current antiretroviral treatments target multiple pathways important for human immunodeficiency virus (HIV) multiplication, including viral entry, synthesis and integration of the DNA provirus, and the processing of viral polyprotein precursors. However, HIV is becoming increasingly resistant to these "combination therapies."
Sagheer A Onaizi et al.
Langmuir : the ACS journal of surfaces and colloids, 23(11), 6336-6341 (2007-04-24)
We present the first study of the directed disassembly of a protein network at the air-water interface by the synergistic action of a surfactant and an enzyme. We seek to understand the fundamentals of protein network disassembly by using rubisco

Related Content

Data Sheet - H6660

Instructions

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service